Suggestions
Iulian Circo
Builder - @i_circo
Iulian Circo is a serial entrepreneur and co-founder of Hyfe, a company that developed the world's most sophisticated acoustic AI for cough detection.12 Hyfe's technology is used daily by researchers, medical professionals, and thousands of people worldwide to monitor, manage, and treat coughing.13
With a background in humanitarian work, Circo has extensive experience in challenging environments, including:
- Leading humanitarian missions in post-conflict and peacekeeping settings like Somalia and DR Congo1
- Running country operations for global non-profits in Swaziland and Mozambique1
- Managing operations for a UN agency in Somalia2
Circo has founded and scaled several impact-driven enterprises in health and fintech sectors.12 He describes himself as a "recovering humanitarian turned entrepreneur".1
Currently, Circo is focused on Hyfe, which he co-founded in March 2020.4 Hyfe aims to bring precision medicine to respiratory health using AI and the world's largest cough database.4 The company's AI models can track and interpret coughs to predict, manage, and treat respiratory diseases.4
In addition to his work with Hyfe, Circo is involved with other ventures as a co-founder, adviser, investor, or board member.1 He has also served on the Board of Directors for Lykke, a Swiss-based company building a global marketplace for financial asset exchange.4
Highlights
Meanwhile, Hyfe's wellness app CoughPro unveils Cough Management feature - world's first - offering AI-driven content for millions suffering from chronic cough.
Probably nothing.
https://lnkd.in/d9YmaeCa
In this piece in the American Pharmaceutical Review, Peter Small discusses the integration of artificial intelligence (AI) in cough medicine development, highlighting its transformative role in drug design and clinical trials.
AI's capability for continuous, precise cough monitoring - the way Hyfe's technology works - is a major advancement in health sciences, overcoming massive historical challenges of reliable symptom quantification.
Novel AI technologies, such as deep learning algorithms for cough pattern recognition, are accelerating drug discovery and complimenting traditional scientific methods to lead to better science, better medicine and and ultimately better healthcare.
Additional trends focus on precision medicine and applying AI for personalized treatments, with ongoing research promising new antitussives and digital therapeutics for cough management.
As the leader and pioneer in AI cough quantification and analysis, Hyfe is of course at the forefront of all this innovation.
https://lnkd.in/dY7HEfDs
